Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review

Several fixed-dose combinations (FDCs) of long-acting bronchodilators (a long-acting muscarinic antagonist [LAMA] plus a long-acting β(2)-agonist [LABA]) are available for the treatment of COPD. Studies of these FDCs have demonstrated substantial improvements in lung function (forced expiratory volu...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David, Østrem, Anders, Thomas, Mike, Welte, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221557/
https://www.ncbi.nlm.nih.gov/pubmed/28115839
http://dx.doi.org/10.2147/COPD.S116719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221557/
https://www.ncbi.nlm.nih.gov/pubmed/28115839
http://dx.doi.org/10.2147/COPD.S116719

Ejemplares similares